China Resources Pharmaceutical: Dong'e Ejiao's net profit attributable to shareholders in the first half of the year was 818 million yuan, an increase of 10.74% year-on-year
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, China Resources Pharmaceutical announced that Dong'e Ejiao published its semi-annual report for the six months ending June 30, 2025. The company achieved a total operating revenue of RMB 3.051 billion, an increase of 11.02% year-on-year; the net profit attributable to shareholders of the listed company was RMB 818 million, an increase of 10.74% year-on-year; the basic earnings per share were RMB 1.27. It plans to distribute a cash dividend of RMB 12.69 per 10 shares (including tax)
According to the Zhitong Finance APP, China Resources Pharmaceutical (03320) announced that Dong'e Ejiao released its semi-annual report for the six months ending June 30, 2025. The company achieved a total operating revenue of RMB 3.051 billion, an increase of 11.02% year-on-year; the net profit attributable to shareholders of the listed company was RMB 818 million, an increase of 10.74% year-on-year; the basic earnings per share were RMB 1.27. It plans to distribute a cash dividend of RMB 12.69 per 10 shares (tax included)